shortagewatch

Home / Various / Ibritumomab Tiuxetan (90Y)

ATC V10XX02 · Therapeutic Radiopharmaceuticals

Ibritumomab Tiuxetan (90Y) shortage

As of 31 Oct 2026, Ibritumomab Tiuxetan (90Y) has a reported shortage in 1 of the 5 countries we track (Italy), covering 1 product.

Countries1/5
Products1packs or presentations
Short since1 Jun 20206.4 years ago
Earliest returnnot givencompany estimate
No return date1products
Main reasonManufacturing problem
GermanyNo reported shortageItaly1 pack shortSpainNo reported shortageAustriaNo reported shortageBelgiumNo reported shortage

Timeline

Italy
20222023202420252026ZEVALINZEVALINtoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITZEVALINCEFT BIOPHARMA S.R.O.1 Jun 2020not givenManufacturing problem
Problemi produttivi

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.